SERPINE1 and diabetes mellitus: Pooled prospective studies adjusted for a comprehensive panel of established diabetes risk factors, allowing for investigation of independent effects of PAI-1 on diabetes risk, though the presence of residual or unknown confounding from individual studies cannot be ruled out.